Ocuphire Pharma, Inc. (OCUP)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Ocuphire Pharma, Inc. (OCUP)
Go deeper and ask any question about OCUP
Company Performance
Current Price
as of Sep 13, 2024$1.30
P/E Ratio
N/A
Market Cap
$34.06M
Description
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.
Metrics
Overview
- HQFarmington Hills, MI
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerOCUP
- Price$1.3+3.17%
Trading Information
- Market Cap$34.06M
- Float90.42%
- Average Daily Volume (1m)116,070
- Average Daily Volume (3m)154,568
- EPS-$0.54
Company
- Revenue$16.45M
- Rev Growth (1yr)-69.73%
- Net Income-$7.77M
- Gross MarginN/A
- EBITDA Margin-748.92%
- EBITDA-$8.33M
- EV-$1.90M
- EV/Revenue-0.12
- P/EN/A
- P/S2.04
Documents
SEC Filings
Factset Street Account